Stocktoria
PAVmed Inc. PAVM
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-07-27
PAVmed Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | — | — | — | — | -17.0% |
| Operating margin | -30712.7% | -1482.9% | -2751.8% | -24161.0% | -10878.6% |
| Net margin | 564.8% | 1326.4% | -2567.0% | -23602.9% | -10069.4% |
| FCF margin | -7376.1% | -1120.3% | -2091.1% | -19237.4% | -8412.0% |
| Return on assets | 1.0% | 129.8% | -193.8% | -164.8% | -57.9% |
| Return on equity | 1.2% | -565.8% | 119.2% | -813.8% | -63.4% |
| Current ratio | 0.17 | 0.06 | 0.45 | 1.07 | 10.93 |
| Revenue growth | -97.6% | 20.0% | 563.1% | -24.6% | — |
Source: SEC EDGAR filings · CIK 0001624326 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.